Executive Team: Medicine, Technology & Execution

Dr Panayiotis Vlamos PhDChief Research Officer (CRO)
Dr. Panayiotis Vlamos is an Associate Professor and Head of the Department of Informatics at the Ionian University. He received his Diploma in Mathematics from the University of Athens and his Ph.D. degree in Mathematics from the National Technical University of Athens, Greece. He is the director of “Bioinformatics and Human Electrophysiology Lab” and of “Computational Modeling Lab” at the Department of Informatics, Ionian University
Dr. Dimitri Papaioannou PhDChief Operations Officer (COO)
Ph.D. in Physics from U of Virginia. M.B.A. from Cornell University. Principal inventor of 17 patents in medical optical imaging for breast cancer detection; Philips. Specialties incl; lean-startup, due-diligence, executive coaching & training, fundraising campaign management. Technological knowledge in life-sciences, medical devices, healthcare & telemedicine technologies, energy, renewables & clean-tech, photonics, optoelectronics, Internet & networking infrastructure.
John KlepperChief Executive Officer (CEO)
Serial entrepreneur with a 14 year successful track record founding and growing immersive technology based businesses. Founded, scaled and exited from an int’l recognised motion capture studio. Founded a software company that delivers a gamified engagement platform to online businesses. Taught art therapy to patients with mental and physical disabilities. Extensive board & advisor experience.

Advisors: Healthcare innovations, technology pioneers

Dr. Ian Robertson, PhDBehavioral Health Advisor
Held the chair of psychology at Trinity College Dublin, and is the founding director of the Trinity College Institute of Neuroscience and co-director of the Neuro-Enhancement for Independent Lives (NEIL) Programme. Professor Robertson’s research on the brain’s attention systems has led to new ways of measuring how humans pay or fail to pay attention. He has developed new therapeutic methods that improve cognitive function in people with attention difficulties, and he has applied these studies in recent years to the challenges of cognitive aging and in the search for methods to delay dementia
Dr. Ioannis Tarnanas, PhDMedical Advisor
PhD in Neuroscience; focus on Alzheimer’s and cognitive performance. 15 years research Dementia & Virtual Reality and previous track record in successful start-ups. Pioneered computational (functional) biomarkers for the early screening of AD as a low cost, internet delivered and noninvasive prognostic tool.
Dr. Stephan Hill, PhDStrategic Advisor
PhD in Economics at Université de Fribourg, Postdoctoral Fellow in Health Economics at Stanford University. 20 years consulting to the health care industry with a focus on insurance and pharmaceutical companies, hospitals and governmental institutions in the health care sector, 5 years of which as CEO of Ernst & Young Consulting Switzerland. Former CEO of KPT Health Insurance Company, former President of Lindenhofgruppe (privat hospital group), former CEO of Swiss Society for Health Policy, President of Bildungszentrum Pflege Bern (largest Nursing School of Switzerland).